| Bioactivity | STAT3-IN-29 (Compound B20) is an inhibitor for STAT3. STAT3-IN-29 inhibits the proliferation of HaCaT cell with IC50 of 0.09 µM, ameliorates the IMQ-induced psoriasis in mouse models[1]. |
| CAS | 2256751-16-1 |
| Formula | C20H15NO6 |
| Molar Mass | 365.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Chen L, et al. Synthesis and biological evaluation of novel isoxazoloquinone derivatives as potent STAT3-targeting antipsoriasis agents[J]. Bioorganic Chemistry, 2024: 107617. |
STAT3-IN-29
CAS: 2256751-16-1 F: C20H15NO6 W: 365.34
STAT3-IN-29 (Compound B20) is an inhibitor for STAT3. STAT3-IN-29 inhibits the proliferation of HaCaT cell with IC50 of
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.